| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.978 | 0.001 | 0.978 | Phosphodiesterase III inhibitor | 0.96 0.001 DBMET00973 0.932 0.001 DBMET00974 | ||
| 0.951 | 0.003 | 0.951 | Cardiotonic | 0.924 0.003 DBMET00973 0.892 0.004 DBMET00974 | ||
| 0.892 | 0.002 | 0.892 | Cyclic AMP phosphodiesterase inhibitor | 0.729 0.003 DBMET00973 0.677 0.004 DBMET00974 | ||
| 0.877 | 0.001 | 0.887 | Phosphodiesterase 3B inhibitor | 0.887 0.001 DBMET00973 0.836 0.001 DBMET00974 | DBMET00973 | |
| 0.86 | 0.001 | 0.871 | Phosphodiesterase 3A inhibitor | 0.871 0.001 DBMET00973 0.836 0.001 DBMET00974 | DBMET00973 | |
| 0.848 | 0.003 | 0.848 | Phosphodiesterase inhibitor | 0.792 0.004 DBMET00973 0.704 0.004 DBMET00974 | ||
| 0.845 | 0.002 | 0.845 | Vasodilator | 0.766 0.004 DBMET00973 0.744 0.004 DBMET00974 | ||
| 0.725 | 0.008 | 0.725 | Toll-Like receptor 7 agonist | 0.64 0.013 DBMET00973 0.581 0.02 DBMET00974 | ||
| 0.715 | 0.008 | 0.715 | Toll-Like receptor agonist | 0.638 0.013 DBMET00973 0.578 0.02 DBMET00974 | ||
| 0.712 | 0.005 | 0.712 | Tumour necrosis factor alpha release inhibitor | 0.343 0.04 DBMET00973 0.317 0.047 DBMET00974 | ||
| 0.636 | 0.013 | 0.636 | Streptokinase A inhibitor | |||
| 0.607 | 0.052 | 0.607 | Alpha-glucosidase inhibitor | 0.273 0.174 DBMET00974 | ||
| 0.558 | 0.009 | 0.714 | Platelet antagonist | 0.714 0.005 DBMET00973 0.654 0.005 DBMET00974 | DBMET00973 | |
| 0.558 | 0.02 | 0.676 | Vasodilator, peripheral | 0.62 0.014 DBMET00973 0.676 0.008 DBMET00974 | DBMET00974 | |
| 0.539 | 0.003 | 0.539 | Phosphodiesterase IV inhibitor | 0.311 0.005 DBMET00973 0.265 0.007 DBMET00974 | ||
| 0.446 | 0.014 | 0.661 | Platelet aggregation inhibitor | 0.661 0.005 DBMET00973 0.598 0.005 DBMET00974 | DBMET00973 | |
| 0.425 | 0.017 | 0.526 | Calcium channel activator | 0.526 0.004 DBMET00973 0.459 0.01 DBMET00974 | DBMET00973 | |
| 0.45 | 0.077 | 0.45 | MAP kinase 1 inhibitor | 0.294 0.187 DBMET00973 0.298 0.182 DBMET00974 | ||
| 0.429 | 0.098 | 0.429 | Transcription factor inhibitor | |||
| 0.34 | 0.022 | 0.34 | Platelet adhesion inhibitor | 0.246 0.051 DBMET00973 0.214 0.064 DBMET00974 | ||
| 0.363 | 0.051 | 0.363 | 12-Lipoxygenase inhibitor | |||
| 0.314 | 0.076 | 0.409 | Vasodilator, coronary | 0.409 0.032 DBMET00973 0.349 0.055 DBMET00974 | DBMET00973 | |
| 0.25 | 0.016 | 0.25 | Cyclin-dependent kinase 3 inhibitor | 0.172 0.058 DBMET00974 | ||
| 0.238 | 0.005 | 0.391 | Phosphodiesterase 4A inhibitor | 0.391 0.004 DBMET00973 0.314 0.005 DBMET00974 | DBMET00973 | |
| 0.24 | 0.043 | 0.283 | MAP kinase kinase 3 inhibitor | 0.283 0.012 DBMET00973 0.217 0.08 DBMET00974 | DBMET00973 | |
| 0.248 | 0.058 | 0.248 | Neuropeptide Y2 antagonist | 0.194 0.13 DBMET00973 0.245 0.062 DBMET00974 | ||
| 0.303 | 0.133 | 0.405 | MAP kinase kinase 6 inhibitor | 0.405 0.056 DBMET00973 0.302 0.134 DBMET00974 | DBMET00973 | |
| 0.188 | 0.02 | 0.347 | Bronchodilator | 0.347 0.007 DBMET00973 0.275 0.011 DBMET00974 | DBMET00973 | |
| 0.216 | 0.048 | 0.216 | Mcl-1 antagonist | |||
| 0.19 | 0.036 | 0.248 | M17 leucyl aminopeptidase inhibitor | 0.202 0.032 DBMET00973 0.248 0.021 DBMET00974 | DBMET00974 | |
| 0.18 | 0.029 | 0.183 | Cathepsin H inhibitor | 0.183 0.028 DBMET00973 0.138 0.056 DBMET00974 | DBMET00973 | |
| 0.163 | 0.016 | 0.163 | Potassium channel activator | 0.098 0.05 DBMET00973 0.132 0.026 DBMET00974 | ||
| 0.143 | 0.003 | 0.143 | Potassium channel (Inward rectifier) activator | 0.067 0.014 DBMET00973 0.094 0.005 DBMET00974 | ||
| 0.142 | 0.003 | 0.142 | Potassium channel (ATP-sensitive) activator | 0.063 0.013 DBMET00973 0.091 0.005 DBMET00974 | ||
| 0.28 | 0.151 | 0.28 | Antibacterial | 0.237 0.189 DBMET00973 | ||
| 0.245 | 0.138 | 0.245 | Thioredoxin glutathione reductase inhibitor | |||
| 0.195 | 0.103 | 0.195 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.194 0.103 DBMET00973 0.177 0.115 DBMET00974 | ||
| 0.097 | 0.015 | 0.212 | Phosphodiesterase 4C inhibitor | 0.212 0.005 DBMET00973 0.149 0.007 DBMET00974 | DBMET00973 | |
| 0.163 | 0.085 | 0.163 | Nitric oxide antagonist | |||
| 0.136 | 0.084 | 0.142 | MAP3K9 inhibitor | 0.142 0.073 DBMET00973 | DBMET00973 | |
| 0.1 | 0.054 | 0.1 | Interleukin 12 antagonist | |||
| 0.056 | 0.019 | 0.239 | Poly(ADP-ribose) polymerase inhibitor | 0.239 0.004 DBMET00973 0.132 0.005 DBMET00974 | DBMET00973 | |
| 0.138 | 0.101 | 0.138 | Heat shock protein 90 alpha antagonist | |||
| 0.051 | 0.017 | 0.213 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.213 0.004 DBMET00973 0.118 0.005 DBMET00974 | DBMET00973 | |
| 0.184 | 0.158 | 0.188 | Transcription factor STAT3 inhibitor | 0.188 0.151 DBMET00974 | DBMET00974 | |
| 0.057 | 0.037 | 0.057 | Maillard reaction inhibitor | |||
| 0.055 | 0.039 | 0.081 | Dihydroorotate oxidase inhibitor | 0.066 0.021 DBMET00973 0.081 0.01 DBMET00974 | DBMET00974 | |
| 0.122 | 0.11 | 0.122 | Heat shock protein 90 antagonist | |||
| 0.182 | 0.172 | 0.245 | Thyroid hormone beta antagonist | 0.245 0.121 DBMET00974 | DBMET00974 | |
| 0.054 | 0.067 | 0.252 | Phosphodiesterase 4B inhibitor | 0.252 0.005 DBMET00973 0.17 0.01 DBMET00974 | DBMET00973 | |
| 0.182 | 0.202 | 0.421 | Antithrombotic | 0.392 0.051 DBMET00973 0.421 0.044 DBMET00974 | DBMET00974 | |
| 0.055 | 0.075 | 0.201 | Phosphodiesterase 4D inhibitor | 0.201 0.011 DBMET00973 0.128 0.025 DBMET00974 | DBMET00973 | |
| 0.102 | 0.123 | 0.246 | Peroxidase inhibitor | 0.246 0.048 DBMET00973 | DBMET00973 | |
| 0.17 | 0.191 | 0.235 | Thyroid hormone antagonist | 0.235 0.133 DBMET00974 | DBMET00974 | |
| 0.08 | 0.105 | 0.093 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.088 DBMET00973 | DBMET00973 | |
| 0.017 | 0.043 | 0.043 | Histamine H3 receptor agonist | 0.043 0.013 DBMET00973 0.028 0.019 DBMET00974 | DBMET00973 | |
| 0.131 | 0.159 | 0.245 | Death-associated protein kinase 2 inhibitor | 0.168 0.07 DBMET00973 0.245 0.014 DBMET00974 | DBMET00974 | |
| 0.168 | 0.197 | 0.303 | Gastrin inhibitor | 0.268 0.059 DBMET00973 0.303 0.031 DBMET00974 | DBMET00974 | |
| 0.018 | 0.046 | 0.039 | Nicotinic acid receptor 2 antagonist | 0.035 0.008 DBMET00973 0.039 0.005 DBMET00974 | DBMET00974 | |
| 0.021 | 0.058 | 0.055 | Nicotinic acid receptor 2 agonist | 0.043 0.018 DBMET00973 0.055 0.012 DBMET00974 | DBMET00974 | |
| 0.224 | 0.267 | 0.357 | 5 Hydroxytryptamine release inhibitor | 0.296 0.169 DBMET00973 0.357 0.109 DBMET00974 | DBMET00974 | |
| 0.166 | 0.21 | 0.201 | Tyrosine 3 hydroxylase inhibitor | 0.201 0.133 DBMET00973 | DBMET00973 | |
| 0.05 | 0.097 | 0.09 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.09 0.042 DBMET00973 | DBMET00973 | |
| 0.044 | 0.095 | 0.09 | Check point kinase 1 inhibitor | 0.09 0.033 DBMET00973 0.063 0.053 DBMET00974 | DBMET00973 | |
| 0.18 | 0.234 | 0.243 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.243 0.075 DBMET00973 0.215 0.128 DBMET00974 | DBMET00973 | |
| 0.007 | 0.079 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 DBMET00973 0.02 0.009 DBMET00974 | DBMET00974 | |
| 0.059 | 0.135 | 0.093 | Falcipain 3 inhibitor | 0.093 0.078 DBMET00974 | DBMET00974 | |
| 0.063 | 0.14 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 DBMET00973 | DBMET00973 | |
| 0.109 | 0.196 | 0.141 | MAP kinase kinase 4 inhibitor | 0.141 0.081 DBMET00973 | DBMET00973 | |
| 0.009 | 0.096 | 0.037 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.037 0.013 DBMET00973 | DBMET00973 | |
| 0.026 | 0.123 | 0.086 | Histamine agonist | 0.086 0.012 DBMET00973 0.048 0.043 DBMET00974 | DBMET00973 | |
| 0.021 | 0.121 | 0.062 | AMPA 4 receptor antagonist | 0.062 0.009 DBMET00973 | DBMET00973 | |
| 0.1 | 0.209 | 0.176 | CF transmembrane conductance regulator agonist | 0.176 0.04 DBMET00973 0.155 0.068 DBMET00974 | DBMET00973 | |
| 0.034 | 0.144 | 0.071 | Beta adrenoreceptor antagonist | 0.06 0.055 DBMET00973 0.071 0.037 DBMET00974 | DBMET00974 | |
| 0.019 | 0.131 | 0.047 | Histamine H2 receptor agonist | 0.047 0.025 DBMET00973 | DBMET00973 | |
| 0.056 | 0.169 | 0.106 | Anabolic | 0.106 0.054 DBMET00973 0.096 0.069 DBMET00974 | DBMET00973 | |
| 0.079 | 0.198 | 0.12 | Interleukin 2 antagonist | 0.109 0.067 DBMET00973 0.12 0.044 DBMET00974 | DBMET00974 | |
| 0.043 | 0.178 | 0.06 | Transcription factor RelA inhibitor | 0.06 0.056 DBMET00973 | DBMET00973 | |
| 0.01 | 0.153 | 0.064 | Nicotinic acid receptor agonist | 0.049 0.015 DBMET00973 0.064 0.01 DBMET00974 | DBMET00974 | |
| 0.045 | 0.211 | 0.095 | Cystathionine beta-synthase inhibitor | 0.095 0.083 DBMET00973 | DBMET00973 | |
| 0.048 | 0.225 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 DBMET00973 | DBMET00973 | |
| 0.125 | 0.309 | 0.242 | 15-Lipoxygenase inhibitor | 0.242 0.171 DBMET00973 | DBMET00973 | |
| 0.041 | 0.229 | 0.122 | Ferrochelatase inhibitor | 0.108 0.063 DBMET00973 0.122 0.053 DBMET00974 | DBMET00974 | |
| 0.045 | 0.233 | 0.146 | GABA C receptor antagonist | 0.146 0.032 DBMET00973 | DBMET00973 | |
| 0.066 | 0.261 | 0.161 | Arachidonic acid antagonist | 0.161 0.075 DBMET00973 | DBMET00973 | |
| 0.037 | 0.234 | 0.093 | Creatine kinase inhibitor | 0.093 0.068 DBMET00973 | DBMET00973 | |
| 0.041 | 0.241 | 0.162 | 5 Hydroxytryptamine 3A agonist | 0.162 0.029 DBMET00973 0.092 0.086 DBMET00974 | DBMET00973 | |
| 0.036 | 0.239 | 0.079 | Glycine receptor agonist | 0.079 0.04 DBMET00973 | DBMET00973 | |
| 0.115 | 0.33 | 0.159 | ErbB-1 antagonist | 0.159 0.158 DBMET00973 | DBMET00973 | |
| 0.008 | 0.223 | 0.063 | AMPA receptor antagonist | 0.063 0.024 DBMET00973 | DBMET00973 | |
| 0.037 | 0.256 | 0.11 | GABA C receptor agonist | 0.11 0.057 DBMET00973 | DBMET00973 | |
| 0.017 | 0.247 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.032 DBMET00973 | DBMET00973 | |
| 0.035 | 0.279 | 0.122 | Protein kinase C zeta inhibitor | 0.122 0.031 DBMET00973 | DBMET00973 | |
| 0.034 | 0.285 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.057 DBMET00973 | DBMET00973 | |
| 0.005 | 0.267 | 0.049 | Kainate receptor antagonist | 0.049 0.022 DBMET00973 | DBMET00973 | |
| 0.025 | 0.296 | 0.105 | Pim-3 kinase inhibitor | 0.105 0.041 DBMET00973 | DBMET00973 | |
| 0.024 | 0.301 | 0.086 | Glycine receptor antagonist | 0.086 0.048 DBMET00974 | DBMET00974 | |
| 0.064 | 0.347 | 0.191 | Non-steroidal antiinflammatory agent | 0.191 0.078 DBMET00973 0.143 0.125 DBMET00974 | DBMET00973 | |
| 0.108 | 0.392 | 0.374 | GABA C receptor rho-3 antagonist | 0.374 0.073 DBMET00973 | DBMET00973 | |
| 0.101 | 0.387 | 0.19 | Insulysin inhibitor | 0.19 0.172 DBMET00974 | DBMET00974 | |
| 0.032 | 0.32 | 0.123 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.123 0.098 DBMET00973 | DBMET00973 | |
| 0.022 | 0.312 | 0.064 | Heat shock protein 90 beta antagonist | 0.064 0.034 DBMET00973 | DBMET00973 | |
| 0.011 | 0.326 | 0.056 | Cyclin A1 inhibitor | 0.056 0.046 DBMET00973 | DBMET00973 | |
| 0.034 | 0.353 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.131 0.068 DBMET00974 | DBMET00974 | |
| 0.019 | 0.35 | 0.098 | GABA aminotransferase inhibitor | 0.098 0.028 DBMET00973 | DBMET00973 | |
| 0.042 | 0.374 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.088 DBMET00974 | DBMET00974 | |
| 0.016 | 0.349 | 0.065 | Cyclin D1 inhibitor | 0.065 0.035 DBMET00973 0.062 0.04 DBMET00974 | DBMET00973 | |
| 0.064 | 0.4 | 0.168 | ATPase inhibitor | 0.168 0.073 DBMET00974 | DBMET00974 | |
| 0.04 | 0.379 | 0.128 | TRKC antagonist | 0.128 0.122 DBMET00973 | DBMET00973 | |
| 0.087 | 0.435 | 0.208 | Sodium/bile acid cotransporter inhibitor | 0.208 0.177 DBMET00974 | DBMET00974 | |
| 0.069 | 0.42 | 0.27 | Lipocortins synthesis antagonist | 0.27 0.028 DBMET00973 | DBMET00973 | |
| 0.04 | 0.404 | 0.149 | Cyclin-dependent kinase 8 inhibitor | 0.149 0.08 DBMET00973 0.135 0.096 DBMET00974 | DBMET00973 | |
| 0.111 | 0.476 | 0.187 | 5 Hydroxytryptamine uptake stimulant | 0.187 0.18 DBMET00973 | DBMET00973 | |
| 0.024 | 0.392 | 0.057 | Phosphodiesterase 1C inhibitor | 0.057 0.056 DBMET00973 | DBMET00973 | |
| 0.032 | 0.403 | 0.139 | I kappa B kinase epsilon inhibitor | 0.139 0.133 DBMET00973 | DBMET00973 | |
| 0.028 | 0.401 | 0.116 | Cytidine deaminase inhibitor | 0.116 0.104 DBMET00974 | DBMET00974 | |
| 0.015 | 0.397 | 0.068 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 DBMET00973 | DBMET00973 | |
| 0.031 | 0.423 | 0.078 | mTOR complex 2 inhibitor | 0.078 0.075 DBMET00973 | DBMET00973 | |
| 0.046 | 0.439 | 0.129 | GABA C receptor rho-2 antagonist | 0.129 0.106 DBMET00973 | DBMET00973 | |
| 0.041 | 0.435 | 0.15 | CDK3/cyclin E inhibitor | 0.102 0.084 DBMET00973 0.15 0.026 DBMET00974 | DBMET00974 | |
| 0.022 | 0.423 | 0.108 | Ribosomal protein S6 kinase inhibitor | 0.108 0.106 DBMET00973 | DBMET00973 | |
| 0.134 | 0.547 | 0.288 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.288 0.229 DBMET00974 | DBMET00974 | |
| 0.024 | 0.445 | 0.087 | GABA C receptor rho-1 antagonist | 0.087 0.084 DBMET00973 | DBMET00973 | |
| 0.024 | 0.449 | 0.152 | MAP kinase kinase 2 inhibitor | 0.152 0.12 DBMET00973 | DBMET00973 | |
| 0.092 | 0.518 | 0.339 | Interleukin 2 agonist | 0.315 0.064 DBMET00973 0.339 0.05 DBMET00974 | DBMET00974 | |
| 0.046 | 0.473 | 0.228 | DNA damaging | 0.228 0.094 DBMET00973 0.163 0.154 DBMET00974 | DBMET00973 | |
| 0.065 | 0.495 | 0.233 | Histamine release inhibitor | 0.233 0.169 DBMET00974 | DBMET00974 | |
| 0.018 | 0.452 | 0.154 | LIM domain kinase 1 inhibitor | 0.154 0.094 DBMET00973 | DBMET00973 | |
| 0.047 | 0.485 | 0.138 | Phospholipase C inhibitor | 0.138 0.133 DBMET00973 | DBMET00973 | |
| 0.067 | 0.509 | 0.173 | RNA-directed DNA polymerase inhibitor | 0.173 0.146 DBMET00973 | DBMET00973 | |
| 0.048 | 0.508 | 0.184 | Neurotrophic factor enhancer | 0.184 0.093 DBMET00973 | DBMET00973 | |
| 0.042 | 0.505 | 0.167 | 3C-like protease (Human coronavirus) inhibitor | 0.167 0.077 DBMET00974 | DBMET00974 | |
| 0.06 | 0.566 | 0.145 | Papain-like protease (SARS coronavirus) inhibitor | 0.123 0.074 DBMET00973 0.145 0.038 DBMET00974 | DBMET00974 | |
| 0.099 | 0.625 | 0.317 | Calcium channel L-type activator | 0.317 0.143 DBMET00973 0.244 0.212 DBMET00974 | DBMET00973 | |
| 0.022 | 0.563 | 0.158 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.158 0.118 DBMET00973 | DBMET00973 | |
| 0.025 | 0.579 | 0.176 | DNA synthesis inhibitor | 0.176 0.16 DBMET00973 | DBMET00973 | |
| 0.01 | 0.585 | 0.153 | Anesthetic general | 0.153 0.111 DBMET00973 | DBMET00973 | |
| 0.022 | 0.608 | 0.185 | 5 Hydroxytryptamine 1E antagonist | 0.185 0.149 DBMET00974 | DBMET00974 | |
| 0.013 | 0.608 | 0.147 | Anticonvulsant | 0.147 0.133 DBMET00973 | DBMET00973 | |
| 0.007 | 0.615 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.044 DBMET00974 | DBMET00974 | |
| 0.028 | 0.672 | 0.202 | Interleukin agonist | 0.169 0.15 DBMET00973 0.202 0.119 DBMET00974 | DBMET00974 | |
| 0.017 | 0.749 | 0.203 | Angiogenesis inhibitor | 0.203 0.167 DBMET00974 | DBMET00974 | |
| 0.004 | 0.745 | 0.063 | Neuraminidase inhibitor | 0.063 0.04 DBMET00974 | DBMET00974 | |
| 0.058 | 0.837 | 0.169 | Peptidyltransferase inhibitor | 0.169 0.149 DBMET00974 | DBMET00974 | |
| 0.02 | 0.815 | 0.097 | Toll-Like receptor 3 antagonist | 0.097 0.056 DBMET00973 | DBMET00973 | |
| 0.005 | 0.815 | 0.049 | Neuraminidase (Influenza A) inhibitor | 0.049 0.025 DBMET00974 | DBMET00974 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |